PLYMOUTH MEETING, Pa., March 19, 2019 /PRNewswire/ — New research from Duke University, published in …
Read More »
NEW HAVEN, Conn., March 18, 2019 /PRNewswire/ — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a …
Read More »
WALTHAM, Mass., March 14, 2019 /PRNewswire/ — Fresenius Medical Care North America’s Renal Therapies Group, …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
NORTH CHICAGO, Ill., March 19, 2019 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today …
Read More »
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …
Read More »
PLYMOUTH MEETING, Pa., March 19, 2019 /PRNewswire/ — New research from Duke University, published in …
Read More »
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced first results from SAUL, a Phase IIIb …
Read More »
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced today that updated results …
Read More »
BOULDER, Colo., March 18, 2019 /PRNewswire/ — Array BioPharma Inc. (NASDAQ: ARRY) today announced that the National Comprehensive Cancer …
Read More »
INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim has filed for regulatory approval of nintedanib in patients with systemic …
Read More »
NEW HAVEN, Conn., March 18, 2019 /PRNewswire/ — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a …
Read More »
SOUTH SAN FRANCISCO, Calif. and ALLSCHWIL, Switzerland, March 15, 2019 /PRNewswire/ — Actelion Pharmaceuticals US, …
Read More »
NEWTON, Mass., March 14, 2019 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical …
Read More »
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics …
Read More »
WALTHAM, Mass., March 14, 2019 /PRNewswire/ — Fresenius Medical Care North America’s Renal Therapies Group, …
Read More »
WHIPPANY, N.J., March 14, 2019 /PRNewswire/ — Bayer presented results today from the CHICO part …
Read More »
Modernizing clinical trials is an agency wide priority. As more diseases are being redefined based …
Read More »
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a collaboration agreement …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
